Temodar (temozolomide)

temozolomide · Merck & Co.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Temodar (temozolomide), covering 2013-01-03 to 2017-07-02. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Resistant Metastatic Melanoma Using Decitabine, Temozolomide and Panobinostat [Phase 1, Phase 2]